By binding with GLP-1 receptors, semaglutide suppresses appetite, increases insulin secretion, delays gastric emptying, stimulates glucose-dependent sections of insulin, and reduces food intake to promote weight loss
While labs are not required for GLP-1 treatment, some patients and providers find it helpful to check markers like hemoglobin A1c (for blood sugar control), lipid panel, thyroid function, and other relevant tests before stopping medication for conception attempts
Dosage and sticking to it make a difference
The most common adverse effectsnausea, diarrhea, vomiting, and constipationtypically diminish over time as patients acclimate to the medication
Thats a real financial difference for people paying out of pocket
PlexusDx Precision Peptide Genetic Test identifies variants in GLP1R (rs6923761) and GIPR (rs1800437) that influence your receptor sensitivity to semaglutide